Stocks to Watch: Speculative Movers, Strategic Shifts, and a Big Bet on Live Entertainment

July 14, 2025

DENVER, Colo., Jul 14, 2025 (247marketnews.com)- Cenorium initiated coverage on Venu (NYSE:VENU) with a strong buy and a $22.30 price target by 2026, citing explosive growth potential from live entertainment venues, hospitality integration, and strategic partnerships with AEG Presents and Aramark. Revenues are projected to scale from $17.8M in 2024 to $600M+ by 2029. With a capital-efficient model and fractional ownership suite strategy, $VENU may be pioneering the next evolution of experiential real estate.

Daré Bioscience (NASDAQ:DARE) released positive interim Phase 3 results for Ovaprene, a potential first-in-class, hormone-free monthly contraceptive. The study continues with no safety concerns, and if approved, Ovaprene would become the first FDA-approved contraceptive of its kind, targeting a large market of women seeking non-hormonal birth control. Bayer holds U.S. commercialization rights contingent on trial completion and payment, with up to $310M in milestones on the table.

SharpLink Gaming (NASDAQ:SBET) is following through from Friday’s announcement that it entered into a definitive agreement with the Ethereum Foundation to purchase 10,000 $ETH at $2,572.37 per token, totaling $25.7 million. The transaction, which closed on July 10, 2025, reflects SharpLink’s bold move to incorporate Ethereum-based assets into its treasury, aligning with growing crypto-integration trends in the digital gaming sector.

Monogram Orthopaedics (NASDAQ:MGRM) is being acquired by Zimmer Biomet (NYSE:ZBH) in a $177 million all-cash deal, enhanced by a CVR worth up to $12.37 per share tied to long-term milestones. Monogram’s advanced semi- and fully autonomous robotic knee surgery platform complements Zimmer’s ROSA Robotics, helping Zimmer strengthen its leadership in surgical robotics and enabling next-gen orthopedic solutions.

BitMine Immersion Technologies (NYSE:BMNR) revealed it now holds over $500 million worth of $ETH, more than doubling its recent $250 million PIPE raise. As of July 14, the company owns 163,142 $ETH at an average price of $3,072.67, per Bloomberg. The move is part of BitMine’s asset-light $ETH treasury strategy, which aims to grow $ETH per share via staking yields, reinvested cash flows, and capital markets optimization.

Presidio Property (NASDAQ:SQFT) is a micro-cap REIT trading below net asset value, with any asset sales, restructuring, or M&A developments likely to drive near-term interest.

OceanPal (NASDAQ:OP) may benefit from sector tailwinds.

Windtree Therapeutics (NASDAQ:WINT), LQR House (NASDAQ:LQR), and Nebius (NASDAQ:NBIU) appear to be among today’s top momentum movers.

Please go to https://247marketnews.com/venu-disclosure/ for additional 247marketnews.com VENU disclosure.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (VENU, DARE, SBET, MGRM, BMNR, OP)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.